Skip to main content

Therapeutic Failure-Related Hospitalisations in the Frail Elderly

Abstract

Background and objective

Although therapeutic failure may be a common cause of drug-related morbidity in older adults, few studies have focused on this problem. The study objective was to determine the frequency and types of, and the factors associated with, therapeutic failure leading to hospitalisation in frail, elderly patients, using a new instrument named the Therapeutic Failure Questionnaire (TFQ).

Methods

The sample included 106 frail, hospitalised elderly patients enrolled in a 1-year-long health service intervention trial at 11 Veterans Affairs Medical Centres. The TFQ was developed by a team of clinicial geriatricians and tested for reliability by two clinical pharmacists and a geriatrician on a sample of 32 patients. To establish validity, a geriatrician retrospectively reviewed the computerised medication records and clinical charts for these patients and applied the TFQ to determine probable therapeutic failures at the time of hospital admission.

Results

Inter- and intra-rater reliability for the TFQ were very good = 0.82 for both). Overall, 11% of patients had one or more probable therapeutic failures (TFQ scores between 4 and 7) leading to hospitalisation. Cardiopulmonary disease was a common ‘indicator’ of therapeutic failure and was often the result of non-adherence. The only factor associated with therapeutic failure occurrence was severe chronic kidney disease (crude odds ratio 5.87; 95% CI 1.20, 28.69; p = 0.01).

Conclusions

The TFQ was able to identify several cases of probable therapeutic failure leading to hospitalisation in frail, elderly patients. Non-adherence to effective therapies for chronic serious cardiopulmonary disease was a common cause of therapeutic failure and represents a target for interventions to reduce hospitalisation. Further research on the occurrence, risk factors for and types of therapeutic failure is needed in a larger cohort of older non-veterans.

This is a preview of subscription content, access via your institution.

Table I
Table II
Table III

References

  1. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255–9

    PubMed  Article  CAS  Google Scholar 

  2. Hanlon JT, Lindblad CI, Mäher R, et al. Geriatric pharmacotherapy. In: Tallis R, Fillit H, editors. Brocklehurst’s textbook of geriatric medicine. 6th ed. London, UK: Churchill Livingstone, 2003: 1289–96

    Google Scholar 

  3. Raschetti R, Morgutti M, Menniti-Ippolito F, et al. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 1999; 54: 959–63

    PubMed  Article  CAS  Google Scholar 

  4. Hohl CM, Dankoff J, Colacone A, et al. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001; 38: 666–71

    PubMed  Article  CAS  Google Scholar 

  5. Grymonpre RE, Mitenko PA, Sitar DS, et al. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 1988; 36: 1092–8

    PubMed  CAS  Google Scholar 

  6. Hallas J, Harvald B, Gram LF, et al. Drug-related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 83–90

    PubMed  Article  CAS  Google Scholar 

  7. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001; 41: 192–9

    CAS  Google Scholar 

  8. Franceschi A, Tuccori M, Bocci G, et al. Drug therapeutic failures in emergency department patients: a university hospital experience. Pharmacol Res 2004; 49: 85–91

    PubMed  Article  Google Scholar 

  9. Hallas J, Worm J, Beck-Nielsen J, et al. Drug-related events and drug utilization in patients admitted to a geriatric hospital department. Dan Med Bull 1991; 38: 417–20

    PubMed  CAS  Google Scholar 

  10. Fried L, Walston J. Frailty and failure to thrive. In: Hazzard WH, Blass JP, Halter JB, et al., editors. Principles of geriatric medicine and gerontology, 5th ed. New York: McGraw-Hill, 2003: 1487–1502

    Google Scholar 

  11. Hallas J, Harvald B, Worm J, et al. Drug-related admissions: results from an intervention program. Eur J Clin Pharmacol 1993; 45: 199–203

    PubMed  Article  CAS  Google Scholar 

  12. Bero LA, Lipton HL, Bird JA. Characterization of geriatric drug-related hospital readmissions. Med Care 1991; 29: 989–1003

    PubMed  Article  CAS  Google Scholar 

  13. Cunningham G, Dodd TRP, Grant DJ, et al. Drug-related problems in elderly patients admitted to Tayside hospitals. Age Ageing 1997; 26: 375–82

    PubMed  Article  CAS  Google Scholar 

  14. Strand LM, Morley PC, Cipolle RJ, et al. Drug-related problems: their structure and function. DICP 1990; 24: 1093–7

    PubMed  CAS  Google Scholar 

  15. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45

    PubMed  Article  CAS  Google Scholar 

  16. Schmader KE, Hanlon JT, Pieper CF, et al. Effectiveness of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004; 116: 394–401

    PubMed  Article  Google Scholar 

  17. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–83

    PubMed  Article  CAS  Google Scholar 

  18. Rosner Fundamentals of biostatistics. 2nd ed. Boston: Duxbury Press, 1986

  19. Higashi T, Shekelle PG, Solomon DH, et al. The quality of pharmacologie care for vulnerable older patients. Ann Intern Med 2004; 140: 714–20

    PubMed  Google Scholar 

  20. Monane M, Bohn RL, Gurwitz JH, et al. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994; 154: 433–7

    PubMed  Article  CAS  Google Scholar 

  21. Gray SL, Williams DM, Pulliam CC, et al. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med 1996; 156: 984–8

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgements

Primary financial support was provided by grants from the National Institute on Aging (R01-AG-15432) and the Veterans Affairs Cooperative Study Program (006). Additional support was provided by grants R01-AG-14158 and P30-AG024827 from the National Institute on Aging, grant K24-AI-51324 from the National Institute of Allergy and Infectious Diseases, the VA Special Fellows Program in Advanced Geriatrics, and from the VFW Endowed Chair in Pharmacotherapy for the Elderly, College of Pharmacy, University of Minnesota. The funding agencies had no role in the design or conduct of the study.

The authors have no conflicts of interest relevant to the content of this study.

We would like to acknowledge the contributions of Richard J. Sloane MPH and Elizabeth C. Clipp RN, PhD for their help with data management and instrument development.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Joseph T. Hanlon.

Appendix

Appendix

Figure A1: Therapeutic failure questionnaire used in the study.

Fig. A1
figure 1

Therapeutic failure questionnaire.

For a copy of the full instructions, please contact the corresponding author.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kaiser, R.M., Schmader, K.E., Pieper, C.F. et al. Therapeutic Failure-Related Hospitalisations in the Frail Elderly. Drugs Aging 23, 579–586 (2006). https://doi.org/10.2165/00002512-200623070-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200623070-00004

Keywords

  • Chronic Obstructive Pulmonary Disease
  • Clinical Pharmacist
  • Therapeutic Failure
  • Cardiopulmonary Disease
  • Crude Odds Ratio